GSK
Income statement / Annual
Last year (2024), GSK plc's total revenue was $31.38 B,
an increase of 3.46% from the previous year.
In 2024, GSK plc's net income was $2.58 B.
See GSK plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$31.38 B |
$30.33 B |
$29.32 B |
$34.11 B |
$34.10 B |
$33.75 B |
$30.82 B |
$30.19 B |
$27.89 B |
$23.92 B |
| Cost of Revenue |
$9.05 B
|
$8.57 B
|
$9.55 B
|
$11.60 B
|
$11.70 B
|
$11.86 B
|
$10.24 B
|
$10.34 B
|
$9.29 B
|
$8.85 B
|
| Gross Profit |
$22.33 B
|
$21.76 B
|
$19.77 B
|
$22.51 B
|
$22.40 B
|
$21.89 B
|
$20.58 B
|
$19.84 B
|
$18.60 B
|
$15.07 B
|
| Gross Profit Ratio |
0.71
|
0.72
|
0.67
|
0.66
|
0.66
|
0.65
|
0.67
|
0.66
|
0.67
|
0.63
|
| Research and Development Expenses |
$6.40 B
|
$6.22 B
|
$5.49 B
|
$5.28 B
|
$5.10 B
|
$4.57 B
|
$3.89 B
|
$4.48 B
|
$3.63 B
|
$3.56 B
|
| General & Administrative Expenses |
$11.02 B
|
$9.39 B
|
$8.37 B
|
$10.98 B
|
$11.46 B
|
$11.40 B
|
$9.92 B
|
$9.67 B
|
$9.37 B
|
$9.23 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.38 B
|
$1.35 B
|
$1.27 B
|
$1.06 B
|
| Selling, General & Administrative Expenses |
$11.02 B
|
$9.39 B
|
$8.37 B
|
$10.98 B
|
$11.46 B
|
$11.40 B
|
$9.92 B
|
$9.67 B
|
$9.37 B
|
$9.23 B
|
| Other Expenses |
$891.00 M
|
-$590.00 M
|
-$523.00 M
|
$57.00 M
|
-$1.94 B
|
-$1.04 B
|
-$292.00 M
|
-$365.00 M
|
-$421.00 M
|
$7.72 B
|
| Operating Expenses |
$18.31 B
|
$15.02 B
|
$13.34 B
|
$16.31 B
|
$14.61 B
|
$14.93 B
|
$15.10 B
|
$15.76 B
|
$16.00 B
|
$12.46 B
|
| Cost And Expenses |
$27.36 B
|
$23.58 B
|
$22.89 B
|
$27.91 B
|
$26.32 B
|
$26.79 B
|
$25.34 B
|
$26.10 B
|
$25.29 B
|
$21.32 B
|
| Interest Income |
$60.00 M
|
$40.00 M
|
$76.00 M
|
$28.00 M
|
$44.00 M
|
$98.00 M
|
$81.00 M
|
$65.00 M
|
$72.00 M
|
$104.00 M
|
| Interest Expense |
$640.00 M
|
$775.00 M
|
$879.00 M
|
$784.00 M
|
$892.00 M
|
$912.00 M
|
$798.00 M
|
$734.00 M
|
$736.00 M
|
$757.00 M
|
| Depreciation & Amortization |
$2.55 B
|
$2.29 B
|
$2.15 B
|
$2.12 B
|
$2.35 B
|
$2.33 B
|
$1.86 B
|
$1.92 B
|
$1.77 B
|
$1.86 B
|
| EBITDA |
$6.67 B |
$9.14 B |
$8.63 B |
$7.76 B |
$10.16 B |
$9.38 B |
$9.35 B |
$8.64 B |
$7.06 B |
$4.18 B |
| EBITDA Ratio |
0.21
|
0.3
|
0.3
|
0.26
|
0.25
|
0.3
|
0.24
|
0.24
|
0.16
|
0.51
|
| Operating Income Ratio |
0.13
|
0.22
|
0.22
|
0.18
|
0.23
|
0.21
|
0.18
|
0.14
|
0.09
|
0.43
|
| Total Other Income/Expenses Net |
-$544.00 M
|
-$681.00 M
|
-$805.00 M
|
-$758.00 M
|
$956.00 M
|
-$740.00 M
|
-$683.00 M
|
-$562.00 M
|
-$659.00 M
|
$204.00 M
|
| Income Before Tax |
$3.48 B
|
$6.06 B
|
$5.63 B
|
$5.44 B
|
$6.97 B
|
$6.22 B
|
$4.80 B
|
$3.53 B
|
$1.94 B
|
$10.53 B
|
| Income Before Tax Ratio |
0.11
|
0.2
|
0.19
|
0.16
|
0.2
|
0.18
|
0.16
|
0.12
|
0.07
|
0.44
|
| Income Tax Expense |
$526.00 M
|
$756.00 M
|
$707.00 M
|
$346.00 M
|
$580.00 M
|
$953.00 M
|
$754.00 M
|
$1.36 B
|
$877.00 M
|
$2.15 B
|
| Net Income |
$2.58 B
|
$4.93 B
|
$4.92 B
|
$4.39 B
|
$5.75 B
|
$4.65 B
|
$3.62 B
|
$1.53 B
|
$912.00 M
|
$8.42 B
|
| Net Income Ratio |
0.08
|
0.16
|
0.17
|
0.13
|
0.17
|
0.14
|
0.12
|
0.05
|
0.03
|
0.35
|
| EPS |
0.63 |
1.22 |
1.22 |
1.37 |
1.44 |
1.17 |
0.92 |
0.39 |
0.24 |
2.18 |
| EPS Diluted |
0.62 |
1.2 |
1.2 |
1.35 |
1.43 |
1.16 |
0.91 |
0.39 |
0.23 |
2.15 |
| Weighted Average Shares Out |
$4.08 B
|
$4.05 B
|
$4.03 B
|
$3.20 B
|
$3.98 B
|
$3.96 B
|
$3.93 B
|
$3.91 B
|
$3.89 B
|
$3.86 B
|
| Weighted Average Shares Out Diluted |
$4.14 B
|
$4.11 B
|
$4.08 B
|
$3.24 B
|
$4.03 B
|
$4.01 B
|
$3.98 B
|
$3.95 B
|
$3.93 B
|
$3.91 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
